To confirm the NF-κB pathway’s regulatory impact on the ROS increase caused by cardamonin, nasopharyngeal carcinoma cells (CNE-2) were additionally exposed to NF-κB inhibitors like BAY 11-7082 and MG132. This evidence concerns the gene NFKB1 and nasopharyngeal carcinoma.